SA
HQL

Sanctuary Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Sanctuary Advisors’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,180
Closed -$172K – 2305
2024
Q4 		$172K Sell
12,180
-1,076
-8% -$15.5K ﹤0.01% 2275
2024
Q3 		$183K Buy
13,256
+1,355
+11% +$20.5K ﹤0.01% 2241
2024
Q2 		$154K Buy
+11,901
New +$161K ﹤0.01% 2215

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return

Sanctuary Advisors's HQL Position: Q1 2025 in Review

Sanctuary Advisors sold out of abrdn Life Sciences Investors (HQL) in Q1 2025, closing a stake of 12,180 shares — an estimated $172K sold.

Sanctuary Advisors first reported a position in HQL in Q2 2024 and held it in 3 quarters. The position peaked at $183K in Q3 2024. 82 funds tracked by Wall St. Rank hold HQL as of Q1 2025.

  • Sanctuary Advisors reported no remaining abrdn Life Sciences Investors position as of Q1 2025 after selling out during the quarter.
  • Sanctuary Advisors sold 12,180 abrdn Life Sciences Investors shares in Q1 2025, an estimated $172K.
  • Sanctuary Advisors first reported a position in abrdn Life Sciences Investors in Q2 2024 and held it in 3 quarters.
  • Sanctuary Advisors's abrdn Life Sciences Investors position peaked at $183K in Q3 2024.
  • 82 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2025.

Based on Sanctuary Advisors's 13F filing for Q1 2025, filed 6 Jan 2026.